Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $77.6300 (2.93%) ($77.6300 - $77.7800) on Mon. May. 15, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.51% (three month average) | RSI | 54 | Latest Price | $77.6300(2.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.1% a day on average for past five trading days. | Weekly Trend | LGND advances 0.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWN(51%) IWM(50%) XAR(49%) XBI(49%) IWO(48%) | Factors Impacting LGND price | LGND will decline at least -1.255% in a week (0% probabilities). VXX(-18%) UUP(-14%) VIXM(-12%) TBT(-9%) SHY(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.255% (StdDev 2.51%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $77.2(0.56%) | 10 Day Moving Average | $76.96(0.87%) | 20 Day Moving Average | $76.86(1%) | To recent high | -1.8% | To recent low | 15.3% | Market Cap | $1.248b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |